News
Zacks Investment Research on MSN6h
CRISPR Therapeutics to Report Q2 Earnings: What's in the Cards?We expect investors to focus on the sales performance of CRISPR Therapeutics’ CRSP sole-marketed product, Casgevy, and other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback